2018

J&J Vision (formerly AMO)/ Tango Study

Clinical Investigation of the TECNIS Next-Generation Intraocular Lenses

Protocol # SUR-CAT-1001  

2016

J&J Vision (formerly AMO)/ Thor Study

Clinical Investigation of the Bacterially-Derived Healon5 Ophthalmic Viscosurgical Device (OVD)

Protocol # VSCO-109-HLN5

ALCON (formerly TRANSCEND) / Compass XT Trial

An observational multicenter clinical study to assess the long-term safety of the Cypass Micro-Stent Glaucoma implant in patients with primary open angle glaucoma who have completed participation in the Compass Trial (#TMI-09-01)

Protocol # TMI-09-01-E

2015

AMO / Grand Tetons Study (IOL-Post Market Study)

Post approval Study of the Technis Toric IOL Extended Cylinder Range, ZCT450, ZCT525, and     ZCT600

Protocol # TIOL-204-EPAS

AERIE / Mercury 1 Trial

A prospective, double-masked, randomized, multi-center, active-controlled, parallel-group 12-month study assessing the safety and ocular hypotensive efficacy of PG324

Ophthalmic Solution compared to AR-13324 Ophthalmic Solution,0.02% and Latanoprost

Ophthalmic Solution, 0.005% in subjects with elevated intraocular pressure.

AMO / Denali Study (IOL-Post Market Study)

Post approval Study of the Technis Toric IOL, Models ZCT300 and ZCT400

Protocol # TIOL-202-TPAS

AMO / Maestro Study

Clinical Investigation of the Technis Symfony Extended Range of Vision IOL, Model ZXR00

B&L / 843 Study

Efficacy and Safety of Loteprednol Etabonate Gel 0.38% vs. Vehicle Gel for treatment of Ocular inflammation and pain following cataract surgery (B&L 843)

2014

AMO / Whitney Study

Qualitative Validation of PRO instruments for the Post Approval study of the Technis Toric Lens, models ZCT300 and ZCT400

Protocol # TIOL-201-VPAS 

AMO / PRO Study

Qualitative Validation of PRO instruments for the assessment of Spectacle Independence and Visual  symptoms

Protocol # QPRO-101-SIVQ

2013

AMO / Low Add IOL

IOL

Protocol # DIOL-106-ZMLA

GLAUKOS / (iStent –  Post Market Study)

iStent Glaucoma implant

Protocol # GTS100-PAS2

TRANSCEND / Compass Trial:

Cypass Glaucoma implant

Protocol # TMI-09-01

2012

VISIOGEN (AMO) / Synchrony Dual Optic IOL

IOL

Protocol # SYNC-601-IOL

2011

ISTA / Xibrom 0.4% – 0.8%

Efficacy and Safety of bromfenac Ophth sol vs. Placebo for treatment of Ocular inflammation and pain associated with cataract surgery (#S00124 )

ALCON / Brinz/Brim

Efficacy & Safety of Fixed combo Brinzolamide 1% & Brimonidine 0.2%  compared to

Brinzolamide 1% and Brimonidine 0.2% (#C-10-033)

AMO / Toric IOL

IOL

Protocol # TIOL-103-TCNS    

HOYA / The iSert 251

Preloaded single piece IOL (#2010-N251)

2010

AMO / VITRAX II

Viscoelastic  

 Protocol # VSCO-106-DISP

2009

ISTA / Xibrom 0.09%

Efficacy and Safety of bromfenac Ophth sol vs. Placebo for treatment of Ocular inflammation and pain associated with cataract surgery (CL-S&E-1205081-P)

2007

STAAR SURGICAL / ICL HYPEROPIC STUDY

Implantable Contact Lens to treat moderate – high myopia 

2004

AMO  / VITRAX

Viscoelastic  

Protocol # VSCO-105-LRCT